Clinical Trials Browser

Completed × Pharmaceutical Preparations × 1 year × Clear all

NCT03753659 2026-03-23

IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)

Phase 2 Completed

30 enrolled 10 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT07418138 2026-02-18

Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver Transplantation

Gastrointestinal

Carcinoma, Hepatocellular

NCT04994158 2025-07-30

MASCOT-R

Myeloproliferative Disorders